Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

10
Number of overlapping holdings
41.7%
% of PPH's 27 holdings also in XLV
16.7%
% of XLV's 60 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in XLV |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.9% | 12.3% | 11.9% | |
JOHNSON & JOHNSON | 6.6% | 7.5% | 6.6% | |
ABBVIE INC | 6.5% | 6.9% | 6.5% | |
MERCK & CO. INC. | 4.8% | 4.3% | 4.3% | |
PFIZER INC | 4.4% | 2.7% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XLV
NOVARTIS AG-ADR | 5.2% | |
ASTRAZENECA PLC-SPONS ADR | 4.9% | |
SANOFI-AVENTIS-ADR | 4.9% | |
NOVO-NORDISK A/S-SPONS ADR | 4.7% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% | |
TEVA PHARMACEUTICAL-SP ADR | 4.1% | |
CENCORA INC | 4.0% | |
ZOETIS INC | 3.2% | |
MCKESSON CORP | 3.1% |
PPH Underweight Relative to XLV
UNITEDHEALTH GROUP INC | -9.0% | |
ABBOTT LABORATORIES | -4.3% | |
THERMO FISHER SCIENTIFIC INC | -3.6% | |
INTUITIVE SURGICAL INC | -3.3% | |
AMGEN INC | -3.1% | |
BOSTON SCIENTIFIC CORP | -2.8% | |
GILEAD SCIENCES INC | -2.6% | |
DANAHER CORP | -2.5% | |
VERTEX PHARMACEUTICALS INC | -2.4% | |
STRYKER CORP | -2.4% |